Nav: Home

Sharing of research data and findings should be the norm in public health emergencies

January 05, 2016

Opting in to data sharing should be the default practice during public health emergencies, such as the recent Ebola epidemic, and barriers to sharing data and findings should be removed to ensure those responding to the emergency have the best available evidence at hand according to Vasee Moorthy and colleagues from the World Health Organization (WHO) in a Policy Forum article published in PLOS Medicine.

In their article the authors outline the findings of a recent WHO-organized consultation that was attended by leading representatives from the scientific community, biomedical journals, industry, funding organizations, and government ministries. Meeting participants collectively identified several key obstacles to sharing research data and findings in times of acute public health need. These included the misperception that disclosure of major findings may negatively prejudice subsequent journal publication; limitations in technical capacity to share information; concerns that data would be analysed and published without due recognition; and the possibility that data sharing could lead to the development of products that source populations are unable to afford.

During the meeting representatives from leading biomedical journals responded with an unequivocal assertion that public disclosure of information of relevance to public health emergencies should not prejudice journal publication of full scientific reports. Meeting participants also recognized that it is not enough for parties to simply agree, in principle, on sharing primary data, as the world must also commit to tackling the technical challenges of implementing data sharing agreements by simplifying and standardizing data capture procedures, assuring data quality, and harmonizing disparate data platforms. How best to effect a shift away from the culture of data ownership toward one of data stewardship remains paramount among broader issues to be addressed.

The authors conclude, "[a]s the quick and transparent dissemination of information is the bedrock of good science and public health practice, it is important that the current trends in data sharing carry over to all matters of acute public health need. Such a global norm would advance the spirit of open collaboration, simplify current mechanisms of information sharing, and potentially save many lives in subsequent outbreaks."

In an accompanying Perspective article Patrick Vallance and colleagues from GlaxoSmithKline note, "[w]e are perpetually in the midst of several health care crises, including those of neglected tropical diseases and other chronic diseases, for which data sharing has the potential to lead to faster and better solutions. As a matter of principle, we should be willing to share data without regards to which disease is being studied."
-end-
FROM THE PLOS MEDICINE MAGAZINE:

Vasee Moorthy and colleagues

Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Wellcome Trust contributed towards the cost of the consultation.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Modjarrad K, Moorthy VS, Millett P, Gsell PS, Roth C, Kieny M-P (2016) Developing Global Norms for Sharing Data and Results during Public Health Emergencies. PLoS Med 13(1): e1001935.doi:10.1371/journal.pmed.1001935

Author Affiliations:

World Health Organization, Geneva, Switzerland

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001935

Contact:

Vasee Moorthy
moorthyv@who.in
World Health Organization, Geneva, Switzerland

Patrick Vallance and colleagues

Funding: There was no specific funding to support this work.

Competing Interests: We have read the journal's policy and have the following conflicts: PV is a President at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. AF is Head of Medical Policy at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. MS is Chief Medical Officer at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. PV is a member of the Editorial Board of PLOS Medicine.

Citation: Vallance P, Freeman A, Stewart M (2016) Data Sharing as Part of the Normal Scientific Process: A View from the Pharmaceutical Industry. PLoS Med 13(1): e1001936. doi:10.1371/journal.pmed.1001936

Author Affiliations:

GlaxoSmithKline, Brentford, Middlesex, United Kingdom;

GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001936

Contact:

Patrick Vallance
patrick.5.vallance@gsk.com
GlaxoSmithKline, United Kingdom,

PLOS

Related Lead Articles:

Poor diet can lead to blindness
An extreme case of 'fussy' or 'picky' eating caused a young patient's blindness, according to a new case report published today [2 Sep 2019] in Annals of Internal Medicine.
What's more powerful, word-of-mouth or following someone else's lead?
Researchers from the University of Pittsburgh, UCLA and the University of Texas published new research in the INFORMS journal Marketing Science, that reveals the power of word-of-mouth in social learning, even when compared to the power of following the example of someone we trust or admire.
UTI discovery may lead to new treatments
Sufferers of recurring urinary tract infections (UTIs) could expect more effective treatments thanks to University of Queensland-led research.
Increasing frailty may lead to death
A new study published in Age and Ageing indicates that frail patients in any age group are more likely to die than those who are not frail.
Discovery could lead to munitions that go further, much faster
Researchers from the U.S. Army and top universities discovered a new way to get more energy out of energetic materials containing aluminum, common in battlefield systems, by igniting aluminum micron powders coated with graphene oxide.
Shorter sleep can lead to dehydration
Adults who sleep just six hours per night -- as opposed to eight -- may have a higher chance of being dehydrated, according to a study by Penn State.
For the brokenhearted, grief can lead to death
Grief can cause inflammation that can kill, according to new research from Rice University.
Lead or follow: What sets leaders apart?
Leaders are more willing to take responsibility for making decisions that affect the welfare of others.
Taking the lead toward witchweed control
A compound that binds to and inhibits a crucial receptor protein offers a new route for controlling a parasitic plant.
How looking at the big picture can lead to better decisions
New research suggests how distancing yourself from a decision may help you make the choice that produces the most benefit for you and others affected.
More Lead News and Lead Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.